Wex Pharmaceuticals Inc.
1040 West Georgia Street, Suite 2100
Vancouver
Bristish Columbia
V6E 4H1
Canada
Tel: 604-683-8880
Fax: 604-683-8868
Website: http://www.wexpharma.com/
Email: wex@wexpharma.com
81 articles about Wex Pharmaceuticals Inc.
-
Wex Pharmaceuticals Inc. Commences Its Quantitative Sensory Testing Clinical Trial Evaluating the Impact of Halneuron(R) on Healthy Volunteers’ Sensory Perceptions
12/11/2023
WEX Pharmaceuticals Inc. ("WEX" or the "Company"), a biotechnology company developing Halneuron® (Tetrodotoxin or TTX) for pain, announced that it has commenced its Quantitative Sensory Testing (QST) clinical trial and is actively recruiting participants into this clinical trial.
-
Wex Pharmaceuticals Inc. Enrolls the First Patient in The Phase 2b Clinical Trial Evaluating the Efficacy and Safety of Halneuron(R) In the Treatment of Chemotherapy-Induced Neuropathic Pain
1/3/2023
WEX Pharmaceuticals Inc., a biotechnology company developing Halneuron® for pain, announced that the first patient has been dosed in its Phase 2B clinical trial evaluating the efficacy and safety of Tetrodotoxin in the treatment of Chemotherapy-Induced Neuropathic Pain.
-
Wex Pharmaceuticals Inc. Recommends Acceptance of Increased Offer by Pharmagesic
1/13/2011
-
Wex Pharmaceuticals Inc. Reports Third Quarter Results
11/15/2010
-
Wex Pharmaceuticals Inc. Retirement of Vice President, Research and Development
10/8/2010
-
Wex Pharmaceuticals Inc. Announces Update on Interim Analysis; Data Monitoring Committe Says TEC-006 Clinical Trial Unlikely to Demonstrate a Clinically Meaningful Treatment-Effect
9/27/2010
-
Wex Pharmaceuticals Inc. Announces Poster Presentation at Scientific Conference
8/26/2010
-
Wex Pharmaceuticals Inc. Reports Second Quarter Results
8/16/2010
-
Wex Pharmaceuticals Inc. Receives Unsolicited Proposal to Purchase From Pharmagesic
7/12/2010
-
Wex Pharmaceuticals Inc. Reports First Quarter Results
5/17/2010
-
Wex Pharmaceuticals Inc. Announces Abstract Accepted for Publication
4/16/2010
-
Wex Pharmaceuticals Inc. to Present at BioFinance 2010 Conference
4/6/2010
-
Wex Pharmaceuticals Inc. Reports Year End Financial Results
2/16/2010
-
Wex Pharmaceuticals Inc. Reports Second Quarter Results
11/13/2009
-
Board Changes at Wex Pharmaceuticals Inc.
10/22/2009
-
CK Life Sciences International Increases Equity Stake in Wex Pharmaceuticals Inc.
10/19/2009
-
Wex Pharmaceuticals Inc. to Present at BioContact 2009 Conference
10/6/2009
-
Wex Pharmaceuticals Inc. Reports First Quarter Results
8/13/2009
-
Wex Pharmaceuticals Inc. to Present at BioContact Québec 2008 Conference
10/1/2008
-
Wex Pharmaceuticals Inc. Reports First Quarter Results
8/14/2008